SE0002211D0 - Methods and compositions for prevention of myopia - Google Patents
Methods and compositions for prevention of myopiaInfo
- Publication number
- SE0002211D0 SE0002211D0 SE0002211A SE0002211A SE0002211D0 SE 0002211 D0 SE0002211 D0 SE 0002211D0 SE 0002211 A SE0002211 A SE 0002211A SE 0002211 A SE0002211 A SE 0002211A SE 0002211 D0 SE0002211 D0 SE 0002211D0
- Authority
- SE
- Sweden
- Prior art keywords
- myopia
- prevention
- prostaglandins
- compositions
- methods
- Prior art date
Links
Landscapes
- Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Exogenous prostaglandins and derivatives of prostaglandins as well as anti-inflammatory agents blocking prostaglandin synthesis are disclosed as useful for the prevention of the development of myopia. The prostaglandins should preferentially be administered topically on the eye, whereas the anti-inflammatory agents may be administered topically on the eye or orally. The administration may be continuous or intermittent.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0002211A SE0002211D0 (en) | 2000-06-13 | 2000-06-13 | Methods and compositions for prevention of myopia |
PCT/SE2001/001339 WO2001095913A1 (en) | 2000-06-13 | 2001-06-13 | Methods and compositions for the prevention of myopia |
AU2001264522A AU2001264522A1 (en) | 2000-06-13 | 2001-06-13 | Methods and compositions for the prevention of myopia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0002211A SE0002211D0 (en) | 2000-06-13 | 2000-06-13 | Methods and compositions for prevention of myopia |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0002211D0 true SE0002211D0 (en) | 2000-06-13 |
Family
ID=20280076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0002211A SE0002211D0 (en) | 2000-06-13 | 2000-06-13 | Methods and compositions for prevention of myopia |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001264522A1 (en) |
SE (1) | SE0002211D0 (en) |
WO (1) | WO2001095913A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA01013257A (en) * | 2001-12-18 | 2003-06-25 | Arturo Jimenez Bayardo | Rofecoxib ophthalmic suspension for the treatment of ocular inflammation and pain. |
US7074827B2 (en) | 2002-10-24 | 2006-07-11 | Sucampo Ag (Usa) Inc. | Method for treating ocular hypertension and glaucoma |
WO2005051413A2 (en) * | 2003-11-26 | 2005-06-09 | Novartis Ag | Disease associated genes |
CN102078614B (en) * | 2010-12-27 | 2012-07-25 | 温州医学院眼视光研究院 | Method for inhibiting shortsightedness and application of adenylate cyclase inhibitor as medicament for inhibiting shortsightedness |
EP2694077A4 (en) * | 2011-04-07 | 2015-01-21 | Sucampo Ag | Method for treating asthenopia |
US20160067238A1 (en) * | 2013-05-06 | 2016-03-10 | Philip Wu | Pharmaceutical composition and uses thereof |
TWI658828B (en) * | 2014-10-31 | 2019-05-11 | 中國醫藥大學 | Pharmaceutical composition for soothing and reducing myopia, and preparation method and application thereof |
CN105998030A (en) * | 2016-05-17 | 2016-10-12 | 温州医科大学 | Application of prostaglandin F2a receptor stimulant in preparation of drug for inhibiting myopia and application method of prostaglandin F2a receptor stimulant |
CN116726006A (en) | 2016-08-19 | 2023-09-12 | 阿拉西斯医药公司 | Ophthalmic pharmaceutical compositions and related uses thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5519030A (en) * | 1993-10-07 | 1996-05-21 | Senju Pharmaceutical Co., Ltd. | Method for prophylaxis and treatment of myopia |
AU5805998A (en) * | 1997-01-02 | 1998-07-31 | Allergan Sales, Inc. | Method for changing the refractive power of an eye |
CA2276287C (en) * | 1997-01-06 | 2007-10-30 | Klaus Trier Aps | Screening method for compounds active in treating myopia and hypermetropia |
WO1999018970A1 (en) * | 1997-10-14 | 1999-04-22 | Senju Pharmaceutical Co., Ltd. | Preventives and remedies for ophthalmic circulatory disturbance |
-
2000
- 2000-06-13 SE SE0002211A patent/SE0002211D0/en unknown
-
2001
- 2001-06-13 AU AU2001264522A patent/AU2001264522A1/en not_active Abandoned
- 2001-06-13 WO PCT/SE2001/001339 patent/WO2001095913A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU2001264522A1 (en) | 2001-12-24 |
WO2001095913A1 (en) | 2001-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR16C1001I2 (en) | "2-OXO-1-PYRROLIDINE DERIVATIVE AND ITS PHARMACEUTICAL APPLICATIONS" | |
NO20025601D0 (en) | Arylmethylamine derivatives for use as tryptase inhibitors | |
EE05287B1 (en) | The so-called clopentanoindoles, their use in the manufacture of a medicament and the pharmaceutical composition containing them | |
TR200200579T2 (en) | Amino-thyrazolpyridine derivatives. | |
YU69902A (en) | New piperazine derivatives | |
RS50140B (en) | Percyquinnin, a process for its production, and its use as a pharmaceutical | |
BRPI0418245A (en) | Nitroxy Prostaglandin Derivatives | |
BR0215184A (en) | orally active taxane derivative pharmaceutical compositions having increased bioavailability | |
DK0738152T3 (en) | Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as chemopreventive and chemotherapeutic agents for colon cancer | |
TR199802060T2 (en) | Use of aminoisoquinolins and aminopyridine derivatives as anti-inflammatory agents. | |
DK1296972T3 (en) | Arylmethylamine derivatives for use as tryptase inhibitors | |
SE0002211D0 (en) | Methods and compositions for prevention of myopia | |
ATE360428T1 (en) | ANALGESIC MEDICINAL PRODUCT | |
TR200001452T2 (en) | Biphenylamidine derivatives. | |
NO20013414D0 (en) | New use of melagatran | |
NO20031410L (en) | Use of distamycin derivatives for the manufacture of drugs | |
EE200100066A (en) | Use of Sodium Chloride to Reduce Gastrointestinal Side Effects Due to Administration of Camptothecin Derivatives | |
WO2002072105A3 (en) | Improved prostanoid therapies for the treatment of glaucoma | |
EE200200098A (en) | Treatment of migraine by administration of alpha-lipoic acid or derivatives thereof | |
HRP20010885B1 (en) | Ethanesulfonyl-piperidine derivatives | |
NO964497L (en) | Means for the treatment of cor pulmonale | |
AR027349A1 (en) | DERIVATIVES OF HETEROCICLIC AMIDAS | |
ATE290374T1 (en) | IGA PRODUCTION INHIBITORS | |
DK1115687T3 (en) | 5,6-Dihydronaphthalenyl derivatives with retinoid-like activity |